ATLASQuest Diagnostics (DGX) earnings date: expected January 11–17
Quest Diagnostics (DGX) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 11–17. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on DGX
| Last price | $251.82 (-0.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.3% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
| Dividend | $3.38 a year (1.34% yield) |
These figures come from the same calibrated model and valuation as the Quest Diagnostics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 11–17 (estimate). One email the day before, with ATLAS’s read on Quest Diagnostics. You can switch it off at any time.
Alert me before DGX reportsFree to start. Creating an account takes under a minute.
DGX earnings at a glance
| Next report | Not announced · expected around January 11–17 (ATLAS estimate) |
|---|---|
| Last report | Oct 22, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +9.9% |
| Average move around a report | ±3.6% (last 4) |
| Sector | Healthcare · Diagnostics & Research |
The expected window is an ATLAS estimate: it takes the typical gap between Quest Diagnostics’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Quest Diagnostics earnings history: last 4 reports
Quest Diagnostics last reported on Oct 22, 2026: EPS of $3.00 against an estimate of $2.85 (+5.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 22, 2026 | $2.85 | $3.00 | +5.3% | Beat | +1.2% |
| Jul 23, 2026 | $2.82 | $3.12 | +10.6% | Beat | +8.6% |
| May 8, 2026 | $0.11 | $0.13 | +18.2% | Beat | -0.5% |
| Apr 21, 2026 | $2.37 | $2.50 | +5.5% | Beat | +3.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for DGX
See the fair value, the probability range and the earnings history of Quest Diagnostics on its ATLAS page.
Quest Diagnostics (DGX) stock analysisPlans from €3.99 a month.
Quest Diagnostics earnings: frequently asked questions
When is Quest Diagnostics (DGX) next earnings date?
Quest Diagnostics has not announced its next report. Its last 3 reports came Oct 22, 2026, Jul 23, 2026, May 8, 2026, so ATLAS estimates the next one around January 11–17. This is an estimate based on that pattern, not a confirmed date.
How often does DGX beat earnings estimates?
Of its last 4 reports with a recorded result, Quest Diagnostics beat the EPS estimate 4 times; the average surprise was +9.9%. Past results do not predict the next one.
How much does DGX move around earnings?
Over its last 4 reports the stock moved an average of 3.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Quest Diagnostics beat earnings estimates last quarter?
Quest Diagnostics last reported on Oct 22, 2026: EPS of $3.00 against an estimate of $2.85 (+5.3% surprise), a beat.
How much does DGX usually move in a day?
On a normal trading day the ATLAS model puts DGX’s one-day range at about ±1.3%, with a 51% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer